×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Nureca Limited | 369.16 | 5.52 | 343.24 | 0.55 | 278.0 | |
| ASARFI HOSPITAL LIMITED | NA | NA | NA | NA | 268 | 26.1 |
| Lotus Eye Hospital And Institu | 137.04 | 5.45 | 135.17 | 0.26 | 264 | 406.0 |
Nureca Limited, with Security Code 543264, is a leading player in the Medical Equipment & Supplies industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.2 | 21.2 | 31.4 | 22.4 | 19.6 | 23.3 | 32.4 | 27.2 | 31.8 | 34.3 |
| Expenses | 25.0 | 24.2 | 30.3 | 26.8 | 24.3 | 26.2 | 35.0 | 31.9 | 31.1 | 35.4 |
| Operating Profit | -3.8 | -3.0 | 1.0 | -4.4 | -4.8 | -2.9 | -2.7 | -4.7 | 0.6 | -1.1 |
| OPM % | -17.98% | -14.05% | 3.31% | -19.79% | -24.32% | -12.5% | -8.2% | -17.39% | 1.95% | -3.14% |
| Other Income | 2.2 | 2.7 | 3.2 | 5.9 | -1.2 | 5.8 | 3.2 | 1.5 | 2.0 | 2.6 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.3 | 0.1 | 0.6 | 0.2 |
| Depreciation | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 |
| Profit before tax | -2.3 | -1.0 | 3.6 | 0.8 | -6.7 | 2.2 | -0.3 | -3.8 | 1.5 | 0.8 |
| Tax % | -21.6% | -22.9% | -26.9% | -90.6% | -34.5% | -44.7% | 138.4% | -14.5% | 33.4% | 33.7% |
| Net Profit | -1.8 | -0.7 | 2.6 | 0.1 | -4.4 | 1.2 | -0.6 | -3.3 | 2.1 | 0.6 |
| EPS in Rs | -1.8 | -0.74 | 2.64 | 0.08 | -4.41 | 1.19 | -0.65 | -3.29 | 0 | 0.55 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27.8 | 21.2 | 21.2 | 31.4 | 22.4 | 17.0 | 20.3 | 31.2 | 26.5 | 31.7 |
| Expenses | 28.7 | 24.7 | 24.1 | 30.0 | 26.6 | 21.4 | 22.6 | 33.5 | 30.5 | 30.5 |
| Operating Profit | -0.9 | -3.5 | -2.9 | 1.4 | -4.3 | -4.4 | -2.4 | -2.4 | -4.0 | 1.3 |
| OPM % | -3.3% | -16.28% | -13.67% | 4.42% | -19.02% | -26.13% | -11.69% | -7.56% | -15.17% | 4.04% |
| Other Income | 1.9 | 2.1 | 2.7 | 3.2 | 5.9 | -1.3 | 5.8 | 3.2 | 1.5 | 2.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.6 |
| Depreciation | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.5 | 0.5 |
| Profit before tax | 0.3 | -2.0 | -0.9 | 3.9 | 0.9 | -6.5 | 2.6 | -0.1 | -3.3 | 2.1 |
| Tax % | 11.5% | -22.5% | -23.9% | -26% | -82.5% | -35.9% | 36.5% | -542.7% | 13.9% | 19.5% |
| Net Profit | 0.3 | -1.5 | -0.7 | 2.9 | 0.2 | -4.1 | 1.7 | -0.5 | -2.8 | 2.5 |
| EPS in Rs | 0.3 | -1.53 | -0.71 | 2.9 | 0.16 | -4.15 | 1.66 | -0.48 | -2.8 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 3% |
| 3 Years: | -23% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 69% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -39% |
| 1 Year: | -8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 2% |
| 3 Years: | -25% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -33% |
| 3 Years: | -73% |
| TTM: | 114% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -39% |
| 1 Year: | -8% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|